Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT07414225
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT07414225
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07414225. Randomized; no masking; primary purpose treatment. Start 2026-06-01 (actual); primary completion 2030-02-25 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
- Acronym
- STAR
- Condition
- Atrial Functional Mitral Regurgitation
- Intervention (Device)
- Transcatheter Edge-to-Edge Repair
- Intervention (Drug)
- Guideline-Directed Medical Therapy (GDMT) for cardiovascular disease
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct07414225- Content hash
181cef9fd64b9de93633a35be733be8b95ae059cf661f2d656e67ccde0aac80c